CYXO — Cyxone AB Share News
0.000.00%
Last trade - 00:00- SEK14.25m
- SEK8.44m
Brief: Cyxone Q2 Pre-Tax Loss Sek 3.8 Million
Brief: Cyxone Q2 Loss After Financial Items Widens To SEK 3.8 Mln
Brief: Cyxone Issues About 1.9 Million Shares To Complete Payment To OxyPharma
Brief: Cyxone AB Q1 Pre-Tax Loss Widesn To Sek 2.7 Million
Brief: Cyxone AB Patent To Be Granted By European Patent Office
Brief: Cyxon:e Cyclotide Shows Promising Initial Results
Brief: Cyxone Q4 Pre-Tax Loss Up At SEK 3.2 Million
Brief: Cyxone Patent Expected To Get Approved By European Patent Office(EPO)
Brief: Cyxone Q3 pre-tax loss widens to SEK 1.5 mln
Brief: Cyxone: Australian patent office approves patent application
Brief: Cyxone: warrants of series TO 2 exercised to about 98.7 pct
Brief: Cyxone Q2 pre-tax loss widens to SEK 2.6 mln
Brief: Cyxone signs agreement to buy Rabeximod
Brief: Cyxone: independent laboratory confirms T20K's ability to prevent and brake multiple sclerosis in animal model
Brief: Cyxone Q4 pre-tax loss SEK 1.3 million
Brief: Cyxone buys patent family to protect its T20K main candidate